Connect your AI

The Beauty Health Company SKIN Convertible Debt

Other financials

Income statement

Revenue$64.9M-6.7%

Gross profit$44.4M-8.5%

Operating income-$1.8M+85.0%

Net income-$6.6M+34.3%

EPS (diluted)-$0.05+37.5%

Balance sheet

Cash & equivalents$204.4M-45.2%

Total debt$125.9M+756%

Total equity$55.2M+19.9%

Total assets$473.2M-29.8%

Cash flow

Operating cash flow-$5.6M-285%

CapEx$224.0K+398%

Free cash flow-$5.8M-296%

Valuation

Market cap$89.75M-61.5%

Enterprise value$11.24M-96.2%

P/S0.3×-0.4×

Profitability

Gross margin64.9%+8.3pp

Operating margin-3.6%-1.6pp

Net margin-2%-0.9pp

FCF margin9.6%—

Returns & leverage

Return on equity-12%-5.4pp

Debt / equity2.3×+2.0×

Current ratio1.8×-5.7×

Where this comes from

Reported directly by The Beauty Health Company in its filing.

Tagged under the XBRL concept us-gaap:ConvertibleDebt.

The official record: The Beauty Health Company’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about The Beauty Health Company's convertible debt.

Connect your AI assistant and see it in context, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is The Beauty Health Company's convertible debt?: The Beauty Health Company (SKIN) reported convertible debt of $344.22M in Q1 2026.